… Emerging prostate cancer molecular biomarkers noted in this review are beginning to
play an important role in improving diagnosis and treatment. The good news is that there is …

… The identification of biomarkers capable of providing a reliable molecular diagnostic test
for prostate cancer (PCa) is highly desirable clinically. We describe here 4 biomarkers, UDP-N-…

… exist for molecular biomarker development in prostate cancer. Tumor heterogeneity may
occur within an individual, meaning two or more independent prostate cancer foci may exist …

… useful molecular biomarker for the detection and diagnosis of patients with prostate
cancer. … as a molecular marker for prostate cancer screening, detection and diagnosis. …

… molecular markers to help define prostate cancer aggressiveness. It is desirable to identify
lethal, curable and insignificant cancer … intratumoral heterogeneity of prostate cancer, not to …

… to identify and validate prognostic and predictive biomarkers that can be applied across
clinical … data on molecular biomarkers for PCa, with an emphasis on the biomarkers and gene …

… Ideally the biomarkers could be measured in a sample that could be … prostate cancer antigen
3 (PCA3) gene (Progensa PCA3; Hologic Inc, Marlborough, MA, USA) is the only molecular …

… progression.82, 83, 84, 85 The aim of this study was to find promising biomarkers that
can meet the unmet clinical needs in prostate cancer patient management. Such biomarkers …

… of biomarkers that are currently showing prognostic potential in prostate cancer research. …
of the kallikrein family may prove to have roles as prostate cancer biomarkers in the future. …

… of molecular biomarkers that promise to be prognostic and that might inform individual
patient management. It highlights current efforts to identify biomarkers … , and cancer-associated …